David Patterson is listed as a director on 12 SEC Form D filings by 1 issuer between Jan 2021 and Dec 2025: Phylos Bioscience, Inc. (Portland, OR — industry reported as "Other" — 2021–2025; $12.2M reported sold to 33 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Nishan Karassik (12 shared filings), Ralph Risch (12 shared filings), Timothy J Gregory (12 shared filings), Mina Mishrikey (8 shared filings), Barbara Peachey (7 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 12 public filings for David Patterson and found 10 differences, 2 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.